Bictegravir/emtricitabine/tenofovir-alafenamide/cobicistat/darunavir/emtricitabine/tenofovir-alafenamideHyperglycaemia and gastrointestinal side effects: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2039卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72544-y

中图分类号：

学科分类号：

摘要：

引用

页码：107 / 107

共 50 条

[1] Bictegravir/emtricitabine/tenofovir-alafenamide/mirtazapineLack of efficacy: case report
Reactions Weekly, 2025, 2050 (1) : 115 - 115
[2] Bictegravir/emtricitabine/tenofovir-alafenamide/doxycyclineLack of efficacy
Reactions Weekly, 2024, 2006 (1) : 142 - 142
[3] Bictegravir/emtricitabine/tenofovir-alafenamideHyperglycaemia and diabetic ketoacidosis: 3 case reports
Reactions Weekly, 2022, 1889 (1) : 87 - 87
[4] Bictegravir/emtricitabine/tenofovir-alafenamide/hydrochlorothiazideVarious toxicities
Reactions Weekly, 2023, 1984 (1) : 113 - 113
[5] Network meta-analysis of darunavir/cobicistat/emtricitabine/tenofovir-alafenamide and elvitegravir/cobicistat/emtricitabine/tenofovir-alafenamide in treatment-naive patients with HIV-1 infection
Van Sanden, S.
Schweikert, B.
Moecklinghoff, C.
Tronczynski, K.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
[6] Bictegravir/emtricitabine/tenofovir-alafenamide/glucoseFanconi syndrome and refeeding syndrome: case report
Reactions Weekly, 2023, 1980 (1) : 90 - 90
[7] Bictegravir/emtricitabine/tenofovir-alafenamide/lenacapavirResistance and poor adherence.: case report
Reactions Weekly, 2024, 2024 (1) : 96 - 96
[8] Bictegravir/emtricitabine/tenofovir alafenamide
不详
AUSTRALIAN PRESCRIBER, 2019, 42 (02) : 68 - 69
[9] Cobicistat/darunavir/cobicistat/darunavir/emtricitabine/tenofovir-alafenamide/darunavir/ritonavirVarious toxicities and off-label use: 9 case reports
Reactions Weekly, 2020, 1833 (1) : 135 - 135
[10] Bictegravir/emtricitabine/tenofovir-alafenamide/Epinephrine/VoriconazoleDisseminated histoplasmosis with gastrointestinal bleeding and lack of efficacy : case report
Reactions Weekly, 2024, 2020 (1) : 102 - 102

← 1 2 3 4 5 →